Vertex Pharmaceutic (VRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2008 | 03-2008 | 12-2007 | 09-2007 | 06-2007 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -187,475 | -96,154 | -391,279 | -305,528 | -198,495 |
| Depreciation Amortization | 15,668 | 7,498 | 27,459 | 20,008 | 13,173 |
| Accounts receivable | 15,955 | 6,495 | 31,603 | 28,265 | 25,734 |
| Accounts payable and accrued liabilities | 3,595 | -1,469 | 17,382 | 10,389 | 2,386 |
| Other Working Capital | 137,971 | -30,749 | 47,300 | 35,481 | 12,792 |
| Other Operating Activity | 12,509 | 8,844 | 15,059 | 11,601 | 8,267 |
| Operating Cash Flow | $-1,777 | $-105,535 | $-252,476 | $-199,784 | $-136,143 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -15,062 | -5,494 | -32,415 | -27,216 | -19,287 |
| Purchase Of Investment | -254,642 | -174,718 | -318,039 | -317,156 | -317,156 |
| Sale Of Investment | 84,372 | 29,178 | 755,620 | 606,247 | 417,330 |
| Other Investing Activity | -946 | -370 | 0 | -444 | -717 |
| Investing Cash Flow | $-186,278 | $-151,404 | $405,166 | $261,431 | $80,170 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 278,000 | 278,000 | N/A | N/A | N/A |
| Debt Repayment | -19,997 | N/A | -42,102 | -42,102 | N/A |
| Common Stock Issued | 124,058 | 113,979 | 31,965 | 21,238 | 11,533 |
| Other Financing Activity | 0 | 0 | -53 | -53 | -53 |
| Financing Cash Flow | $382,061 | $391,979 | $-10,190 | $-20,917 | $11,480 |
| Exchange Rate Effect | -37 | -7 | -8 | 78 | 40 |
| Beginning Cash Position | 355,663 | 355,663 | 213,171 | 213,171 | 213,171 |
| End Cash Position | 549,632 | 490,696 | 355,663 | 253,979 | 168,718 |
| Net Cash Flow | $193,969 | $135,033 | $142,492 | $40,808 | $-44,453 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,777 | -105,535 | -252,476 | -199,784 | -136,143 |
| Capital Expenditure | -15,062 | -5,494 | -32,415 | -27,216 | -19,287 |
| Free Cash Flow | -16,839 | -111,029 | -284,891 | -227,000 | -155,430 |